Inspire Investing’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Sell |
2,238
-512
| -19% | -$64.4K | 0.03% | 766 |
|
|
2025
Q1 | $304K | Buy |
2,750
+861
| +46% | +$95.2K | 0.04% | 785 |
|
|
2024
Q4 | $258K | Sell |
1,889
-580
| -23% | -$79.2K | 0.03% | 809 |
|
|
2024
Q3 | $284K | Sell |
2,469
-2,054
| -45% | -$237K | 0.03% | 806 |
|
|
2024
Q2 | $623K | Sell |
4,523
-7,773
| -63% | -$1.07M | 0.07% | 283 |
|
|
2024
Q1 | $1.7M | Buy |
12,296
+6,045
| +97% | +$834K | 0.17% | 145 |
|
|
2023
Q4 | $824K | Sell |
6,251
-5,247
| -46% | -$691K | 0.09% | 236 |
|
|
2023
Q3 | $1.29M | Sell |
11,498
-10,526
| -48% | -$1.18M | 0.17% | 164 |
|
|
2023
Q2 | $2.08M | Buy |
22,024
+1,287
| +6% | +$121K | 0.25% | 95 |
|
|
2023
Q1 | $2.1M | Buy |
20,737
+5,282
| +34% | +$535K | 0.27% | 93 |
|
|
2022
Q4 | $1.85M | Buy |
15,455
+13,506
| +693% | +$1.61M | 0.24% | 91 |
|
|
2022
Q3 | $207K | Buy |
+1,949
| New | +$207K | 0.03% | 517 |
|
|
2020
Q2 | – | Sell |
-76
| Closed | -$7K | – | 642 |
|
|
2020
Q1 | $7K | Buy |
+76
| New | +$7K | ﹤0.01% | 720 |
|
|
2018
Q1 | – | Sell |
-7
| Closed | -$1K | – | 515 |
|
|
2017
Q4 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 880 |
|